FTC "unfairness" standard
This article was originally published in The Tan Sheet
Nonprescription Drug Manufacturers Association is part of a 36-member coalition that sent a Feb. 15 letter to all conferees working on Federal Trade Commission reauthorization legislation (HR 2243). The letter, also signed by the Cosmetic, Toiletry and Fragrance Association, urges support of "continued restrictions on the FTC's unfairness authority for advertising" and supports a Senate version of the bill, which makes permanent a ban on FTC's use of unfairness rulemaking authority for ads. The House bill places no restrictions on FTC's rulemaking authority ("The Tan Sheet" Sept. 27, 1993, In Brief)
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC